Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non–small-cell lung cancer
GV Scagliotti, U Pastorino, JF Vansteenkiste… - Journal of clinical …, 2012 - ascopubs.org
… This study aimed to determine whether three preoperative cycles of gemcitabine plus cisplatin
followed by radical surgery provides a reduction in the risk of progression compared with …
followed by radical surgery provides a reduction in the risk of progression compared with …
Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group
…, Lung Cancer Study Group - JNCI: Journal of the …, 1991 - academic.oup.com
… The LCSG's subsequent randomized phase II trial, LCSG study #881, was therefore … , in
the neoadjuvant, preoperative therapy of unresectable stage IIIA non-small-cell lung cancer. …
the neoadjuvant, preoperative therapy of unresectable stage IIIA non-small-cell lung cancer. …
[HTML][HTML] … randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative …
M Yamasaki, T Yasuda, M Yano, M Hirao… - Annals of …, 2017 - Elsevier
… Study treatment This study is an open-label, randomized phase II trial. Eligible patients
were randomly assigned to either preoperative ACF chemotherapy followed by surgery (ACF …
were randomly assigned to either preoperative ACF chemotherapy followed by surgery (ACF …
… preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trial
O Shiraishi, T Makino, M Yamasaki, K Tanaka… - Esophagus, 2021 - Springer
… In conclusion, this multi-institutional, randomized phase II study showed that both two-
and three courses of DCF NAC were equally tolerable and feasible in patients with locally …
and three courses of DCF NAC were equally tolerable and feasible in patients with locally …
Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin, or gemcitabine and cisplatin as perioperative chemotherapy for …
…, V Harter, S Culine, VESPER Trial Investigators - European Urology, 2021 - Elsevier
… in our randomized phase III study, approved by the Ethics Committee CPP ROUEN NO
on April 19, 2012 and the competent authority on February 27, 2012 (Clinical trial registry: …
on April 19, 2012 and the competent authority on February 27, 2012 (Clinical trial registry: …
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
JA Roth, HI Pass, MM Flanagan, GM Graeber… - The Journal of thoracic …, 1988 - Elsevier
… We conclude that preoperative and postoperative cisplatin, vindesine, and bleomycin …
chemotherapy in phase II trials indicated to us that a randomized trial of preoperative …
chemotherapy in phase II trials indicated to us that a randomized trial of preoperative …
… cancer: neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study
JA Martinez-Pineiro, MG Martin, F Arocena… - The Journal of …, 1995 - Elsevier
… effects of cisplatin on surgery, we did not find any difference in the perioperative morbidity
… To date, we are aware of only 5 completed phase III studies of neoadjuvant chemotherapy (…
… To date, we are aware of only 5 completed phase III studies of neoadjuvant chemotherapy (…
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
H Bleiberg, T Conroy, B Paillot, AJ Lacave… - European journal of …, 1997 - Elsevier
Patients with measurable or evaluable locally advanced or metastatic squamous cell carcinoma
of the oesophagus were treated with cisplatin (CDDP), 100 mg/m 2 , combined with 5-…
of the oesophagus were treated with cisplatin (CDDP), 100 mg/m 2 , combined with 5-…
[HTML][HTML] … to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
AP Barbour, ET Walpole, GT Mai, EH Barnes… - Annals of …, 2020 - Elsevier
… We report a randomised, non-comparative phase II trial to determine whether adding
docetaxel to CF chemotherapy (DCF), with or without RT, can significantly improve the major …
docetaxel to CF chemotherapy (DCF), with or without RT, can significantly improve the major …
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
J Tepper, MJ Krasna, D Niedzwiecki, D Hollis… - Journal of clinical …, 2008 - ascopubs.org
… A number of studies have been run to test the efficacy of preoperative radiochemotherapy
compared with surgery alone 14-18 ; FU and cisplatin were the most common drugs employed…
compared with surgery alone 14-18 ; FU and cisplatin were the most common drugs employed…
相关搜索
- randomised phase ii trial preoperative chemotherapy
- randomised phase ii study cisplatin alone
- multicentre randomised phase ii trial
- prospective randomized phase iii study
- randomised phase ii study oxaliplatin capecitabine
- lung cancer randomized phase iii study
- phase iii trial preoperative paclitaxel
- randomized controlled phase iii trial
- randomized phase ii study cell carcinoma
- neoadjuvant cisplatin international phase iii trial
- cisplatin and fluorouracil phase ii study
- phase ii trial locally advanced carcinoma
- randomised phase ii study carboplatin paclitaxel
- randomised phase ii study 5 fu
- randomised phase ii trial radiation therapy
- iii study preoperative cisplatin and gemcitabine